Literature DB >> 23774700

The effects of dipeptidyl-peptidase-IV inhibitor, vildagliptin, on the exocrine pancreas in spontaneously diabetic Goto-Kakizaki rats.

Hiroki Mizukami1, Wataru Inaba, Kazunori Takahashi, Kosuke Kamata, Kentaro Tsuboi, Soroku Yagihashi.   

Abstract

OBJECTIVES: The risk of adverse effects of dipeptidyl peptidase-4 inhibitors on the exocrine pancreas, particularly the high risk of pancreatitis, is controversial. In this study, we examined the exocrine pancreatic function and structure in spontaneously diabetic Goto-Kakizaki (GK) rats treated with a dipeptidyl peptidase-4 inhibitor.
METHODS: Male GK rats and normal Wistar rats 4 weeks of age were treated with vildagliptin (VG; 30 mg/kg/d) for 18 weeks. Subsequently, exocrine pancreatic pathology and function in treated animals were compared to those in untreated animals.
RESULTS: In GK rats, VG treatment suppressed elevated serum concentrations of amylase and lipase, reduced lymphocytic infiltration around ducts, around vessels, and in acinar areas, and reduced the frequency of apoptotic acinar cells and ductule formation (both of which occurred more frequently in GK rats than Wistar rats). However, VG treatment had no effect on the proliferation rate of pancreatic duct glandular cells (which was low in GK rats) and of cells in the main ducts, peripheral ducts, and acini (which was similar in all groups).
CONCLUSIONS: Perturbations of exocrine pancreatic function and structure in GK rats are ameliorated by long-term VG treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774700     DOI: 10.1097/MPA.0b013e318287c9b5

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

Review 1.  Incretin-based therapies in prediabetes: Current evidence and future perspectives.

Authors:  Georgios S Papaetis
Journal:  World J Diabetes       Date:  2014-12-15

2.  Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma.

Authors:  Chiaki Uchida; Hiroki Mizukami; Yutaro Hara; Takeshi Saito; Satoko Umetsu; Akiko Igawa; Sho Osonoi; Kazuhiro Kudoh; Yasuhiko Yamamoto; Hiroshi Yamamoto; Soroku Yagihashi; Kenichi Hakamada
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.